Rasha Hussein
Principal IP Developer
Molecule GmbH
I'm working on
a month ago
Nucleixa™: A fully validated, proprietary targeted molecular nanotechnology engineered for high-precision payload transport and cellular penetration. Designed as a turnkey, plug-and-play asset for cosmetics, personal care, and therapeutic applications.
I'm looking for
a month ago
Corporate licensing, exclusive IP acquisition, and commercial partnerships with global chemical, cosmetic, and pharmaceutical CDMOs.
About
Principal Developer specializing in targeted molecular delivery systems and developer of Nucleixa™.
Direct Contact:
Email: rasha.work.00@gmail.com
Rasha Hussein
Principal IP Developer
Molecule GmbHWork experience
Principal IP Developer
Top industry applications
Not enough data yet.
Results may appear later and can be imperfect.
Results may appear later and can be imperfect.
Open to opportunities in
Computational BiologyDrug DeliveryMaterials ScienceNanotechnology
Last updated Sep 2026
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.